Filing metadata

Accession number
0001209191-22-063026
Form type
Form 4
Filer
CRISPR Therapeutics AG
CIK
CIK 1674416
Filed
Dec 30, 2022
Reporting period
Dec 28, 2022
Description
Insider transaction

Explore SEC Filings Hub